BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1705369)

  • 1. Effects and levels of coenzyme Q10 in lung and liver in bleomycin-hamster model of lung fibrosis.
    Giri SN; Graver DF
    Toxicol Lett; 1991 Jan; 55(1):47-53. PubMed ID: 1705369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical mechanisms for the attenuation of bleomycin-induced lung fibrosis by treatment with niacin in hamsters: the role of NAD and ATP.
    O'Neill CA; Giri SN
    Exp Lung Res; 1994; 20(1):41-56. PubMed ID: 7514122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of niacin on bleomycin-induced increases in myeloperoxidase, prolyl hydroxylase, and superoxide dismutase activities and collagen accumulation in the lungs of hamsters.
    O'Neill CA; Giri SN
    J Biochem Toxicol; 1992; 7(4):229-39. PubMed ID: 1284083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung fibrosis is ameliorated by pirfenidone fed in diet after the second dose in a three-dose bleomycin-hamster model.
    Iyer SN; Margolin SB; Hyde DM; Giri SN
    Exp Lung Res; 1998; 24(1):119-32. PubMed ID: 9457473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose and regimen effects of poly ICLC, an interferon inducer, in a multi-dose bleomycin model of interstitial pulmonary fibrosis.
    Wild JS; Hyde DM; Giri SN
    Pharmacol Toxicol; 1994 Jul; 75(1):42-8. PubMed ID: 7526360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
    Iyer SN; Wild JS; Schiedt MJ; Hyde DM; Margolin SB; Giri SN
    J Lab Clin Med; 1995 Jun; 125(6):779-85. PubMed ID: 7539478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of delayed treatment with transforming growth factor-beta soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters.
    Wang Q; Hyde DM; Gotwals PJ; Giri SN
    Exp Lung Res; 2002 Sep; 28(6):405-17. PubMed ID: 12217209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CoQ10 enhances the efficacy of airway basal stem cell transplantation on bleomycin-induced idiopathic pulmonary fibrosis in mice.
    Liu H; Liu S; Jiang J; Zhang Y; Luo Y; Zhao J; Xu J; Xie Y; Liao W; Wang W; Nie Y; Li S; Deng W
    Respir Res; 2022 Feb; 23(1):39. PubMed ID: 35219329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a bleomycin hamster model of subchronic lung fibrosis.
    Zia S; Hyde DM; Giri SN
    Pathology; 1992 Jul; 24(3):155-63. PubMed ID: 1279506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of bleomycin-induced pulmonary fibrosis in the hamster by cis-4-hydroxy-l-proline.
    Riley DJ; Kerr JS; Berg RA; Ianni BD; Pietra GG; Edelman NH; Prockop DJ
    Am Rev Respir Dis; 1981 Apr; 123(4 Pt 1):388-93. PubMed ID: 6164320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of bleomycin-induced lung fibrosis by treatment with the platelet activating factor receptor antagonist WEB 2086 in hamsters.
    Giri SN; Sharma AK; Hyde DM; Wild JS
    Exp Lung Res; 1995; 21(2):287-307. PubMed ID: 7539741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of platelet-activating factor receptors in lung and alveolar macrophages in the bleomycin-hamster model of pulmonary fibrosis.
    Chen J; Ziboh V; Giri SN
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1219-27. PubMed ID: 9067307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peplomycin sulfate and pulmonary fibrosis: hydroxyproline, uronic acid, proline hydroxylase and glucosamine 6-phosphate synthetase in lungs of hamsters treated with peplomycin.
    Yoshida A; Yamada T; Hiramatsu M; Kiuchi H; Sekiya S; Kawaguchi T; Yamamoto K; Yu SY
    J Antibiot (Tokyo); 1983 Aug; 36(8):1067-75. PubMed ID: 6195141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dibutyrylcyclic adenosine monophosphate on bleomycin-induced lung toxicity in hamsters.
    O'Neill CA; Giri SN; Wang Q; Perricone MA; Hyde DM
    J Appl Toxicol; 1992 Apr; 12(2):97-111. PubMed ID: 1372923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of an interferon inducer bropirimine on bleomycin-induced lung fibrosis in hamsters.
    Zia S; Hyde DM; Giri SN
    Pharmacol Toxicol; 1992 Jul; 71(1):11-8. PubMed ID: 1381833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis.
    Giri SN; Hyde DM; Braun RK; Gaarde W; Harper JR; Pierschbacher MD
    Biochem Pharmacol; 1997 Dec; 54(11):1205-16. PubMed ID: 9416971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin.
    Wang QJ; Giri SN; Hyde DM; Li C
    Biochem Pharmacol; 1991 Aug; 42(5):1115-22. PubMed ID: 1714734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine.
    Nici L; Santos-Moore A; Kuhn C; Calabresi P
    Cancer; 1998 Nov; 83(9):2008-14. PubMed ID: 9806661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of repeated administration of N-acetyl-L-cysteine on sulfhydryl levels of different tissues and bleomycin-induced lung fibrosis in hamsters.
    Giri SN; Hyde DM; Schiedt MJ
    J Lab Clin Med; 1988 Jun; 111(6):715-24. PubMed ID: 2453601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of three cysteine pro-drugs on bleomycin-induced lung fibrosis in hamsters.
    Hyde DM; Giri SN; Schiedt MJ; Krishna GA
    Pathology; 1990 Apr; 22(2):93-101. PubMed ID: 1700359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.